Cellev8 Nutrition Inc.
Other OTCTotal Valuation
Cellev8 Nutrition Inc. carries a market capitalization of 10.72M, placing it among publicly traded companies globally.
| Market Cap | 10.72M |
| Enterprise Value | N/A |
Share Statistics
Cellev8 Nutrition Inc. currently has 70.40M shares outstanding.
| Shares Outstanding | 70.40M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Cellev8 Nutrition Inc. trades at a trailing price-to-earnings ratio of 12.36. The price-to-sales ratio is 22.30, and the price-to-book ratio stands at -0.34.
| PE Ratio | 12.36 |
| PS Ratio | 22.30 |
| PB Ratio | -0.34 |
| P/TBV Ratio | -1.09 |
| P/FCF Ratio | -10.39 |
| P/OCF Ratio | -10.26 |
Financial Position
Cellev8 Nutrition Inc. maintains a current ratio of 0.04, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.04 |
| Quick Ratio | 0.00 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | -2.83 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | 207.74 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 0.90 |
Stock Price Statistics
Cellev8 Nutrition Inc.'s stock has declined approximately -91.01124% over the past 52 weeks. The 50-day moving average sits at 0.08, while the 200-day moving average is 0.12.
| Beta (5Y) | N/A |
| 52-Week Price Change | -91.01124% |
| 50-Day Moving Average | 0.08 |
| 200-Day Moving Average | 0.12 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Cellev8 Nutrition Inc. generated 480,160.00 in revenue and converted that into 866,546.00 in net income, yielding earnings per share of -0.03. EBITDA reached -1.32M, while operating income came in at -1.34M.
| Revenue | 480,160.00 |
| Gross Profit | 160,985.00 |
| Operating Income | -1.34M |
| Pretax Income | -1.96M |
| Net Income | 866,546.00 |
| EBITDA | -1.32M |
| EBIT | -1.34M |
| Earnings Per Share (EPS) | -0.03 |
Balance Sheet
Total book value stands at -31.78M, with working capital of -9.84M providing operational flexibility.
| Cash & Cash Equivalents | 2,063.00 |
| Total Debt | N/A |
| Net Debt | 4.63M |
| Equity (Book Value) | -31.78M |
| Book Value Per Share | -0.50 |
| Working Capital | -9.84M |
Cash Flow
Cellev8 Nutrition Inc. produced -1.04M in operating cash flow over the past twelve months. After subtracting -13,000.00 in capital expenditures, free cash flow totaled -1.06M - equivalent to -0.02 per share.
| Operating Cash Flow | -1.04M |
| Capital Expenditures | -13,000.00 |
| Free Cash Flow | -1.06M |
| FCF Per Share | -0.02 |
Margins
Cellev8 Nutrition Inc. operates with a gross margin of 33.53, reflecting its pricing power and cost economics. The operating margin of -278.19 and net profit margin of 180.47 provide insight into operational efficiency.
| Gross Margin | 33.53 |
| Operating Margin | -278.19 |
| Pretax Margin | -407.55 |
| Profit Margin | 180.47 |
| EBITDA Margin | -274.96 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -9.54 |
| FCF Yield | -9.62 |
Stock Splits
Cellev8 Nutrition Inc.'s most recent stock split took place on July 2, 2014 with a 235:1 split ratio.
| Last Split Date | 7/2/2014 |
| Split Ratio | 235:1 |
Scores
Cellev8 Nutrition Inc. posts an Altman Z-Score of -150.50, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -150.50 |